Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (17)

2023

  1. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma

    World Journal of Gastrointestinal Oncology, Vol. 15, Núm. 2, pp. 268-275

  2. Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis

    NMR in Biomedicine, Vol. 36, Núm. 9

  3. Study of SARS-CoV-2 in semen from asymptomatic donors with the presence of virus in nasopharyngeal swabs

    Reproductive BioMedicine Online, Vol. 47, Núm. 6

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Importance of BRCA mutation for the current treatment of pancreatic cancer beyond maintenance

    World Journal of Gastroenterology, Vol. 27, Núm. 39, pp. 6515-6521

  3. Liquid biopsy approach to pancreatic cancer

    World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287

2020

  1. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

    Cancers, Vol. 12, Núm. 4

  2. Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12

2019

  1. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

2015

  1. Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

    BioMed Research International, Vol. 2015

2014

  1. Serum cytokine profile in patients with pancreatic cancer

    Pancreas, Vol. 43, Núm. 7, pp. 1042-1049

  2. Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

    Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720

2013

  1. Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  2. Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure

    International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635

2008

  1. Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells

    British Journal of Dermatology, Vol. 159, Núm. 2, pp. 370-378